Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LLP homolog, long-term synaptic facilitation factor (LLPH) is a protein coding gene primarily expressed in human neurons and nucleoli. LLPH encodes a protein with RNA binding ability and is predicted to be involved in neuronal development, including dendrite extension and regulation of dendritic spine growth, critical for synaptic function and plasticity. The gene is located on chromosome 12 in humans. LLPH is named after the Aplysia protein linked to long-term synaptic facilitation, but its exact biological role in humans appears related to neuronal structure rather than direct signaling. There are currently no drugs targeting human LLPH, and it is not widely recognized as a therapeutic target or biomarker in human disease
None known; no drugs described that directly modulate LLPH
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LLP homolog, long-term synaptic facilitation factor (LLPH).